Edwards Lifesciences EW
NYSE EW
$86.16 -0.56 (-0.65%)
As of: Sep 9, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Revenue Growth (1y) (2010 - 2026)

Analysis

Edwards Lifesciences (EW) Revenue Growth (1y) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 13.02%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 18.54%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 13.73%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 9.42%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 7.53%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 13.63%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 7.95%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 13.08%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 7.30%
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn 4.80%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.63%
Mar 31, 2026 16.70%
Dec 31, 2025 13.26%
Sep 30, 2025 14.67%
Jun 30, 2025 11.89%
Mar 31, 2025 6.23%
Dec 31, 2024 9.43%
Sep 30, 2024 8.93%
Jun 30, 2024 7.08%
Mar 31, 2024 8.89%
Dec 31, 2023 194.58%
Sep 30, 2023 -5.73%
Jun 30, 2023 -6.91%
Mar 31, 2023 -8.94%
Dec 31, 2022 -67.67%
Sep 30, 2022 0.67%
Jun 30, 2022 -0.15%
Mar 31, 2022 10.24%
Dec 31, 2021 11.58%
Sep 30, 2021 14.84%